0.75Open0.75Pre Close0 Volume1 Open Interest7.50Strike Price0.00Turnover0.00%IV336.51%PremiumOct 18, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.75Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.52Leverage Ratio--Theta--Rho--Eff Leverage--Vega
iCAD Inc Stock Discussion
NEWS
iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium
iCAD, Inc. announces partnership with Densitas and showcases ProFound Cloud at SBI symposium, highlighting advancements in breast cancer detection technology
NASHUA, N.H., April 11, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will sh...
NEWS
iCAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting
$Forge Global (FRGE.US)$
$iCAD Inc (ICAD.US)$
$Iris Energy (IREN.US)$
IREN can run big with the gaps it has.
No comment yet